Literature DB >> 23961007

Infantile hemangiomas: A review.

Alison B Callahan1, Michael K Yoon.   

Abstract

Infantile hemangiomas (IH) are the most common eyelid and orbital tumors of childhood. Although they are considered benign lesions that have a generally self-limited course, in the periocular region, they have the potential to cause amblyopia, strabismus, and severe disfigurement. The decision for treatment can be a source of anxiety for patients, parents, and physicians alike. There are numerous treatment modalities, including emerging therapies that may make treatment safer and more effective than ever before. This review discusses our current understanding of this disease, its management, and future therapies.

Entities:  

Keywords:  Capillary hemangioma; Infantile hemangioma; Propranolol treatment

Year:  2012        PMID: 23961007      PMCID: PMC3729453          DOI: 10.1016/j.sjopt.2012.05.004

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN: 1319-4534


  74 in total

1.  Targeting NF-κB in infantile hemangioma-derived stem cells reduces VEGF-A expression.

Authors:  Shoshana Greenberger; Irit Adini; Elisa Boscolo; John B Mulliken; Joyce Bischoff
Journal:  Angiogenesis       Date:  2010-09-25       Impact factor: 9.596

2.  Guidelines of care for hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Committee.

Authors:  I J Frieden; L F Eichenfield; N B Esterly; R Geronemus; S B Mallory
Journal:  J Am Acad Dermatol       Date:  1997-10       Impact factor: 11.527

3.  Serial excision of facial hemangiomas.

Authors:  Jonathan Kulbersh; Marcelo Hochman
Journal:  Arch Facial Plast Surg       Date:  2011 May-Jun

4.  Eyelid necrosis following intralesional corticosteroid injection for capillary hemangioma.

Authors:  F C Sutula; A T Glover
Journal:  Ophthalmic Surg       Date:  1987-02

5.  Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation.

Authors:  M L Bennett; A B Fleischer; S L Chamlin; I J Frieden
Journal:  Arch Dermatol       Date:  2001-09

6.  GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations.

Authors:  J Leon-Villapalos; K Wolfe; L Kangesu
Journal:  Br J Plast Surg       Date:  2005-04

7.  Outpatient treatment of periocular infantile hemangiomas with oral propranolol.

Authors:  Kathryn M Haider; David A Plager; Daniel E Neely; Jennifer Eikenberry; Anita Haggstrom
Journal:  J AAPOS       Date:  2010-06       Impact factor: 1.220

8.  A randomized controlled trial of propranolol for infantile hemangiomas.

Authors:  Marcia Hogeling; Susan Adams; Orli Wargon
Journal:  Pediatrics       Date:  2011-07-25       Impact factor: 7.124

9.  A unique microvascular phenotype shared by juvenile hemangiomas and human placenta.

Authors:  P E North; M Waner; A Mizeracki; R E Mrak; R Nicholas; J Kincannon; J Y Suen; M C Mihm
Journal:  Arch Dermatol       Date:  2001-05

Review 10.  MRI characteristics and classification of peripheral vascular malformations and tumors.

Authors:  Hicham Moukaddam; Jeffrey Pollak; Andrew H Haims
Journal:  Skeletal Radiol       Date:  2008-11-20       Impact factor: 2.199

View more
  9 in total

1.  Pediatric Ophthalmology: Changing with the times.

Authors:  Jonathan C Song
Journal:  Saudi J Ophthalmol       Date:  2012-07-01

Review 2.  Vascular Anomalies of the Head and Neck Region.

Authors:  S C Nair
Journal:  J Maxillofac Oral Surg       Date:  2018-01-05

3.  Morphological, genetic and clinical correlations in infantile hemangiomas and their mimics.

Authors:  Alina Costina Luca; Ingrith Crenguţa Miron; Laura Mihaela Trandafir; Elena Cojocaru; Ioana Alexandra Pădureţ; Mioara Florentina Trandafirescu; Alin Constantin Iordache; Elena Ţarcă
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

4.  Approach to Infantile Hemangiomas.

Authors:  Anil Abraham; Anupa Mary Job; Gillian Roga
Journal:  Indian J Dermatol       Date:  2016 Mar-Apr       Impact factor: 1.494

5.  Development and characterization of a nanoemulsion containing propranolol for topical delivery.

Authors:  Tatiana Zanela da Silva Marques; Ralph Santos-Oliveira; Luciana Betzler de Oliveira de Siqueira; Verônica da Silva Cardoso; Zaida Maria Faria de Freitas; Rita de Cássia da Silva Ascenção Barros; Ana Lúcia Vazquez Villa; Mariana Sato de Souza de Bustamante Monteiro; Elisabete Pereira Dos Santos; Eduardo Ricci-Junior
Journal:  Int J Nanomedicine       Date:  2018-05-14

6.  Propranolol Participates in the Treatment of Infantile Hemangioma by Inhibiting HUVECs Proliferation, Migration, Invasion, and Tube Formation.

Authors:  Weili Yuan; Xukai Wang
Journal:  Biomed Res Int       Date:  2021-01-27       Impact factor: 3.411

7.  The effectiveness of oral propranolol for infantile hemangioma on the head and neck region: A case series.

Authors:  Prasetyanugraheni Kreshanti; Nandya Titania Putri; Valencia Jane Martin; Chaula Luthfia Sukasah
Journal:  Int J Surg Case Rep       Date:  2021-06-19

Review 8.  Infantile Hemangioma: A Brief Review.

Authors:  Madalina Bota; Gheorghe Popa; Cristina Blag; Alexandru Tataru
Journal:  Clujul Med       Date:  2015-01-28

9.  Lycium barbarum polysaccharide induced apoptosis and inhibited proliferation in infantile hemangioma endothelial cells via down-regulation of PI3K/AKT signaling pathway.

Authors:  Lin Lou; Guo Chen; Bing Zhong; Feng Liu
Journal:  Biosci Rep       Date:  2019-08-19       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.